| Product NDC: | 17478-012 |
| Proprietary Name: | Benztropine Mesylate |
| Non Proprietary Name: | Benztropine Mesylate |
| Active Ingredient(s): | 1 mg/mL & nbsp; Benztropine Mesylate |
| Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 17478-012 |
| Labeler Name: | Akorn, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA012015 |
| Marketing Category: | NDA AUTHORIZED GENERIC |
| Start Marketing Date: | 20120808 |
| Package NDC: | 17478-012-02 |
| Package Description: | 5 AMPULE in 1 CARTON (17478-012-02) > 2 mL in 1 AMPULE |
| NDC Code | 17478-012-02 |
| Proprietary Name | Benztropine Mesylate |
| Package Description | 5 AMPULE in 1 CARTON (17478-012-02) > 2 mL in 1 AMPULE |
| Product NDC | 17478-012 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Benztropine Mesylate |
| Dosage Form Name | INJECTION |
| Route Name | INTRAMUSCULAR; INTRAVENOUS |
| Start Marketing Date | 20120808 |
| Marketing Category Name | NDA AUTHORIZED GENERIC |
| Labeler Name | Akorn, Inc. |
| Substance Name | BENZTROPINE MESYLATE |
| Strength Number | 1 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Anticholinergic [EPC],Antihistamine [EPC],Cholinergic Antagonists [MoA],Histamine Receptor Antagonists [MoA] |